REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: SEER-MEDICARE ANALYSIS

被引：0
|
作者：
Hamlin, P. [1 ]
Satram-Hoang, S. [2 ]
Reyes, C. [3 ]
Hoang, K. [2 ]
Guduru, S. [2 ]
Skettino, S. [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] QD Res Inc, Granite Bay, CA USA
[3] Genentech Inc, San Francisco, CA 94080 USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P843
引用
收藏
页码：353 / 353
页数：1
相关论文
共 50 条
  • [21] Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis
    Ip, Andrew
    Mutebi, Alex
    Wang, Tongsheng
    Jun, Monika
    Kalsekar, Anupama
    Navarro, Fernando Rivas
    Wang, Anthony
    Kamalakar, Rajesh
    Sacchi, Mariana
    Elliott, Brian
    ADVANCES IN THERAPY, 2024, 41 (03) : 1226 - 1244
  • [22] Evaluation of the prognostic utility of bone marrow biopsy in diffuse large B-Cell lymphoma in the SEER-Medicare dataset
    Luan, Danny
    Wu, Yiyuan
    Goldstein, Jordan
    Rutherford, Sarah
    Leonard, John P.
    Martin, Peter
    LEUKEMIA & LYMPHOMA, 2021, 62 (08) : 1850 - 1859
  • [23] Burden of illness and outcomes in second-line large B-cell lymphoma treatment: real-world analysis of Medicare beneficiaries
    Kilgore, Karl M.
    Mohammadi, Iman
    Wong, Anny C.
    Snider, Julia T.
    Cheng, Paul
    Schroeder, Amy
    Patel, Anik R.
    FUTURE ONCOLOGY, 2021, 17 (35) : 4837 - 4847
  • [24] Real-World Treatment Patterns, Healthcare Resource Utilization, Costs, and Survival Among Medicare Beneficiaries with Diffuse Large B-Cell Lymphoma (DLBCL)
    Garg, Mahek
    Huntington, Scott F.
    Puckett, Justin
    Kamal-Bahl, Sachin
    Raut, Monika
    Ryland, Katherine Elizabeth
    Doshi, Jalpa
    BLOOD, 2022, 140 : 10814 - 10815
  • [25] Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population
    Byun, Ja Min
    Lee, Jeong-Ok
    Kang, Beodeul
    Kim, Ji-Won
    Kim, Se Hyun
    Kim, Jin Won
    Kim, Yu Jung
    Lee, Keun-Wook
    Bang, Soo-Mee
    Lee, Jong Seok
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (09): : 503 - 510
  • [26] A SEER-Medicare Analysis of the Cost of Disease Progression After Frontline R-CHOP in Diffuse Large B-Cell Lymphoma
    Burke, John M.
    Wang, Rongrong
    Hossain, Farah
    Li, Jia
    Masaquel, Anthony
    Qiheng, Summera
    Matasar, Matthew
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S360 - S360
  • [27] Evaluation of the Prognostic Utility of Bone Marrow Biopsy in Diffuse Large B-Cell Lymphoma: A SEER-Medicare Linked Database Analysis
    Luan, Danny
    Wu, Yiyuan
    Goldstein, Jordan S.
    Rutherford, Sarah C.
    Leonard, John P.
    Martin, Peter
    BLOOD, 2020, 136
  • [28] REAL-WORLD TREATMENT PATTERNS AND COSTS IN RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES
    Mutebi, A.
    Jun, M.
    Flores, C.
    Wang, Z.
    Wang, A.
    Elliot, B.
    Navarro, F. R.
    Kalsekar, A.
    VALUE IN HEALTH, 2022, 25 (07) : S394 - S394
  • [29] Real-world treatment patterns and outcomes in Japanese patients with large B-cell lymphoma after two systemic therapies
    Liao, L.
    Chhibber, A.
    Zhang, G.
    Kim, J.
    Keshishian, A.
    Chung, S.
    Shrestha, S.
    Ando, H.
    Takaura, K.
    Sakai, M.
    Mutebi, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1338 - S1338
  • [30] Real-world costing analysis for diffuse large B-cell lymphoma in British Columbia
    Costa, S.
    Scott, D. W.
    Steidl, C.
    Peacock, S. J.
    Regier, D. A.
    CURRENT ONCOLOGY, 2019, 26 (02) : 108 - 113
12345